9/4/2009

Thermo Fisher Scientific has agreed to pay about $470 million to acquire BRAHMS, a Germany-based in vitro diagnostics test firm. The deal is expected to be finalized this month and will allow Thermo Fisher to integrate BRAHMS with its Analytical Technologies Segment's Specialty Diagnostics unit.

Related Summaries